Amsterdam, Netherlands
November 10 - November 11, 2006
This congress follows and completes "ART in the 21st Century: A Time for Reflection and New Horizons - Part 1" which took place in Nice last year.
As we move ahead in the 21st Century and the first child conceived through IVF is now more that 25 years old, it is time not only to reflect on the development of the field of human ART but also to look forward to the next generation of technologies that will impact patient treatment in the years to come.
Certainly there is a global movement to reducing the number of embryos transferred, in some countries reducing this to a single embryo, while there is also a growing voice regarding the safety of ART procedures.
The aim of this symposium is to address the issue of how we, as a medical and scientific community, can move to reduce the number of embryos transferred, ultimately to a singleton, while also addressing concerns regarding the potential problems to parents and children associated with IVF.
OBJECTIVES
At the end of this symposium the participants will be able to:
- Ascertain the role and efficacy of different ovarian stimulation regimens;
- Evaluate the clinical significance of in vitro maturation;
- Assess the safety of current laboratory procedures;
- Describe advances in embryo assessment criteria to facilitate single embryo transfer.
Serono Symposia International Foundation (www.seronosymposia.org) has submitted this program "ART in the 21st Century: A Time for Reflection and New Horizons - Part II" (Amsterdam, The Netherlands - November 10-11, 2006) for accreditation by the Italian Ministry of Health (Reference Number: 4282-260523), the European Accreditation Council for Continuing Medical Education (EACCME), the RIZIV (Belgium) and the Royal College of Physicians (UK).
